MOSCOW (Reuters) – The Belarusian health ministry has registered Russia’s Sputnik V vaccine, becoming the first country outside Russia to do so, Russia’s RDIF sovereign wealth fund said on Monday.
Belarus, a close ally of Russia, began conducting clinical trials using the vaccine on volunteers on Oct. 1 and also reviewed data received during Russia’s Phase III clinical trials, the Russian Direct Investment Fund said.
(Reporting by Anastasia Teterevleva; writing by Tom Balmforth; Editing by Hugh Lawson)
